Arvinas, Inc. (ARVN)
NASDAQ: ARVN · Real-Time Price · USD
10.22
-0.07 (-0.68%)
At close: Apr 28, 2026, 4:00 PM EDT
10.22
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:30 PM EDT
Arvinas Market Cap
Arvinas has a market cap or net worth of $652.40 million as of April 28, 2026. Its market cap has increased by 43.30% in one year.
Market Cap
652.40M
Enterprise Value
-20.90M
1-Year Change
43.30%
Ranking
Category
Stock Price
$10.22
Market Cap Chart
Since September 27, 2018, Arvinas's market cap has increased from $516.15M to $652.40M, an increase of 26.40%. That is a compound annual growth rate of 3.14%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tenax Therapeutics | 719.30M |
| Alpha Tau Medical | 712.00M |
| Lexicon Pharmaceuticals | 711.78M |
| BridgeBio Oncology Therapeutics | 702.69M |
| Gyre Therapeutics | 679.38M |
| Forte Biosciences | 671.93M |
| Prime Medicine | 655.19M |
| First Tracks Biotherapeutics | 631.04M |